Search Results 321-330 of 19705 for CLL

  1. Spinal Cord Lymphoma Clinical Trials - Mayo Clinic Research

    ... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. GB5121 In Adult Subjects With Relapsed/Refractory ...

  2. Publications

    Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index. Blood Cancer J 2021 ...

  3. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). It is composed of a patient survey (n=250), a physician survey (n=100), and a practice survey completed by each site ...

  4. Medical Research & Education - Mayo Clinic News Network

    This episode of "Tomorrow's Cure" explores how a type of blood cancer, chronic lymphocytic leukemia (CLL), is hard to detect early in its development and ...

  5. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  6. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  7. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  8. Cancer Clinical Trials - Medical Professionals

    Jacksonville, Fla. The purpose of this study is to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients who ...

  9. Duvelisib (oral route) - Side effects & dosage - Mayo Clinic

    Duvelisib is used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or after 2 or more types of treatment that ...

  10. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...